Studies on the affinity of 6-[(n-(cyclo)aminoalkyl)oxy]-4H-chromen-4-ones for sigma 1/2 receptors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Studies on the affinity of 6-[(n-(cyclo)aminoalkyl)oxy]-4H-chromen-4-ones for sigma 1/2 receptors

Published:2021 Issue: Volume: Page:
ISSN:2632-8682
Container-title:RSC Medicinal Chemistry
language:en
Short-container-title:RSC Med. Chem.

Author:

Deuther-Conrad Winnie¹²³⁴⁵^ORCID,Diez-Iriepa Daniel⁶⁷⁸⁹,Iriepa Isabel⁶⁷⁸⁹^ORCID,López-Muñoz Francisco¹⁰¹¹¹²¹³⁸,Martínez-Grau María Angeles¹⁴¹⁵⁹,Gütschow Michael¹⁶¹⁷¹⁸¹⁹⁵^ORCID,Marco-Contelles José²⁰²¹²²²³⁹^ORCID

Affiliation:

1. Helmholtz-Zentrum Dresden-Rossendorf

2. Institute of Radiopharmaceutical Cancer Research

3. Department of Neuroradiopharmaceuticals

4. 04318 Leipzig

5. Germany

6. Department of Organic and Inorganic Chemistry

7. University of Alcalá

8. Madrid

9. Spain

10. Faculty of Health

11. Camilo José Cela University of Madrid (UCJC)

12. Spain; Neuropsychopharmacology Unit

13. “Hospital 12 de Octubre” Research Institute

14. MG Drug Discovery Consulting

15. 28034 Madrid

16. Pharmaceutical Institute

17. Pharmaceutical & Medicinal Chemistry

18. University of Bonn

19. 53121 Bonn

20. Laboratory of Medicinal Chemistry

21. IQOG

22. CSIC

23. 28006 Madrid

Abstract

Chromenone derivatives were identified as σ₁ and σ₂ receptor ligands (12, 20) and multitarget small molecules (7).

Funder

Universidad Camilo José Cela

Universidad de Alcalá

Ministerio de Ciencia, Innovación y Universidades

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/MD/D1MD00105A

Reference33 articles.

1. Novel Sigma-1 receptor antagonists: from opioids to small molecules: what is new?

2. Sigma-2 receptor: past, present and perspectives on multiple therapeutic exploitations

3. Structure of the σ1 Receptor and Its Ligand Binding Site

4. Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation

5. Imaging sigma receptors in the brain: New opportunities for diagnosis of Alzheimer’s disease and therapeutic development

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The proof of concept of 2-{3-[N-(1-benzylpiperidin-4-yl)propyl]amino}-6-[N-methyl-N-(prop-2-yn-1-yl)amino]-4-phenylpyridine-3,5-dicarbonitrile for the therapy of neuropathic pain;Bioorganic Chemistry;2024-09

2. Synthesis and Characterization of Hybrid Structures Based on Furan-2(3H)-ones and Chromen-4(4H)-ones—Potential Antibacterial Activity;ECSOC 2023;2023-11-15

3. The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents;ACS PHARMACOL TRANSL;2022

4. The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents;ACS Pharmacology & Translational Science;2022-10-12

5. Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress;European Journal of Medicinal Chemistry;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3